However, the absolute lymphocentric modus operandi of the anti-PD-1 treatment was challenged, as macrophage polarization towards an M1 phenotype was likely responsible for the therapeutic efficacy of an ICI regimen in a preclinical glioma model [56]. This evidence concerns the gene PDCD1 and central nervous system cancer.